The standard eligibility criteria for weight loss treatment with semaglutide mirror the FDAs approval criteria for Wegovy
Esther Lyuh, a family medicine practitioner and preventive medicine expert
This can be beneficial for individuals with autoimmune diseases, where the immune system mistakenly attacks healthy tissues, leading to chronic inflammation
GIP is another hormone your body releases after you eat that helps your body release insulin when your blood sugar rises in such instances
A trailblazer in this field is semaglutide, the first GLP-1 receptor agonist approved for weight loss and type 2 diabetes management, marking a transformative step in peptide therapy innovation
Putting It Together If your lipid panel was part of the reason you started looking into GLP-1 treatment, youre likely to see meaningful improvements, particularly in triglycerides, within the first few months